Synthesis and characterization of a novel heterocycle: 1-Substituted-4- arylazamethylene-6-arylpyrazolo[5,4-d]-1,3-oxazine

Journal of Heterocyclic Chemistry

Volumn 45, Issue 2, 2008, Pages 365-369

  He, Kunlun ^a   Lv, Houjun ^b   Wang, Junbo ^b   Qiu, Guofu ^a   Hu, Xianming ^a  

^a WUHAN UNIVERSITY   (China)

^b Sundia MedTech Co Ltd   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4 [(6 CHLORO(3 PYRIDYL))AZAMETHYLENE] 6 (4 CHLOROPHENYL) 1 PHENYLPYRAZOLO[5,4 D]1,3 OXAZINE; 6 (4 CHLOROPHENYL) 4 [(4 CHLOROPHENYL)AZAMETHYLENE] 1 PHENYLPYRAZOLO[5,4 D]1,3 OXAZINE; 6 (4 CHLOROPHENYL) 4 [(4 METHOXYLPHENYL)AZAMETHYLENE] 1 PHENYLPYRAZOLO[5,4 D]1,3 OXAZINE; 6 (4 CHLOROPHENYL) 4 [(4 METHYLPHENYL)AZAMETHYLENE] 1 PHENYLPYRAZOLO[5,4 D]1,3 OXAZINE; 6 (6 CHLORO(3 PYRIDYL)) 4 [( CHLOROPHENYL)AZAMETHYLENE] 1 PHENYLPYRAZOLO[5,4 D]1,3 OXAZINE; 6 (6 CHLORO(3 PYRIDYL)) 4 [(4 CHLOROPHENYL)AZAMETHYLENE] 1 (2 PYRIDYL)PYRAZOLO[5,4 D] 1,3 OXAZINE; 6 (6 CHLORO(3 PYRIDYL)) 4 [(4 METHOXYPHENYL)AZAMETHYLENE] 1 PHENYLPYRAZOLE[5,4 D] 1,3 OXAZINE; 6 (6 CHLORO(3 PYRIDYL)) 4 [(4 METHYLPHENYL)AZAMETHYLENE] 1 (2 PYRIDYL)PYRAZOLO[5,4 D] 1,3 OXAZINE; 6 (6 CHLORO(3 PYRIDYL)) 4 [(4 METHYLPHENYL)AZAMETHYLENE] 1 PHENYLPYRAZOLE[5,4 D] 1,3 OXAZINE; HYDROCHLORIC ACID; OXAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ACYLATION; ARTICLE; CHEMICAL STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE; ROOM TEMPERATURE; SYNTHESIS; X RAY CRYSTALLOGRAPHY;

EID: 40949088638     PISSN: 0022152X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jhet.5570450211     Document Type: Article

References (26)

1. Wang, H.; Ganesan, A. J. Org. Chem. 1998, 63, 2432-2433.
2. Wang, S.; Ryder, H;. Pretswell, I.; Depldge, P.; Milton'J.; Hancox,T,C.; Dale.I.; Dangerfiel, W.; Cherlton,P.; Faint, R.; Dodd, R.; Hassan, S. Bioorg. Med. Chem. Lett. 2002, 12, 571-574.
3. Snider, B. B.; Zeng, H. Heterocycles. 2003, 61, 173-182.
4. Shcherbakova, I.; Balandrin, M, F.; Fox, J.; Ghatah, A.; Heaton, W. L.; Conklin, R. L. Bioorg. Med. Chem. Lett. 2005, 15, 1557-1560
5. Mazurkiewicz, R. Monatsh. Chem. 1989, 120, 973-980.
6. Molina, P.; Alajarin, M.; Vidal, A.; Foces-Foces, M.; Cano, F. H. Tetrahedron 1989, 45, 4263-4286.
7. He, F.; Snider, B. B. J. Org. Chem. 1999, 64, 1397-1399.
8. Canestrari, S.; Mar'in, A.; Sgarabotto, P.; Righi, L.; Greci, L. J. Chem. Soc., Perkin Trans. 2000, 2, 833-838.
9. (a) Wang, H.; Ganesan, A. J. Org. Chem. 2000, 65, 1022-1030;
10. (b) Wang, H.; Ganesan, A. J. Comb. Chem. 2000, 2, 186-194.
11. Freed, J. D.; Hart, D. J.; Magomedov, N. A. J. Org. Chem. 2001, 66, 839-852.
12. Hart, D. J.; Magomedov, N. A. J. Am. Chem. Soc. 2001, 123, 5892-5899.
13. Bonne, D.; Dekhane, M.; Zhu, J. P. Org. Lett. 2005, 7, 5285-5288.
14. (a) Liu, J.-F.; Lee, J. Dalton, A. M.; Bi, G.; Baldino, C. M.; MCElory, E.; Brown, M. Tetrahedron. Lett. 2005, 46, 1241-1244;
15. (b) Liu, J.-F.; Ye, P.; Zhang, B.; Bi, G.; Sargent, K.; Yu, L.; Yohannes, D.; Baldino, C. M. J. Org. Chem. 2005, 70, 6339-6345.
16. Zhichikin, P.; Kesicki, E.; Treiberg, J.; Bourdon, L.; Ronsheim, M.; Ooi, H, C.; White, S.;Judkins, A.; Fairfax, D. Org. Lett. 2007, 9, 1415-1418
17. Selby, T. P.; Birch, L. D. WO Patent 03/032731 A1, 2003; Chem. Abstr. 2003, 138: 316207.
18. Pathak, U. S.; Gandhi, S.; Rathod,I. S. Indian J. Chem. Sect. B. 1994, 33, 734-737.
19. Reddy, P, S, N.; Reddy, P.; Reddy, G. J.; Rao, K. S. Heterocycl. Commun. 2003, 9, 503-506.
20. Liu, H; He, X. H.; Choi, H. S.; Yang, K.Y.; Woodmansee, D.; Wang, Z. C.; Ellis, D. A.; Wu, B. G.; He, Y. ; Nguyen, T. N. WO Patent 06/047516 A1, 2006 ; Chem. Abstr. 2006, 144: 450725.
21. 6): δ 9.15 (d, J = 2.1, 0.25H), 8.81 (d, J = 2.1, 0.75H), 8.53 (dd, J = 8.4, 2.4, 0.25H), 8.31 (dd, J = 8.4, 2.4, 0.75H), 8.39 (s, 0.75H), 8.05 (d, J = 8.1, 1.5H), 7.82 (d, J = 8.1, 0.5H), 7.81-7.74 (m, 1H), 7.65-7.58 (m, 2H), 7.50-7.43 (m, 1H), 7.30-7.18 (m, 3.5H), 6.91 (d, J = 8.1, 0.5H), 6.58 (s, 0.25H), 2.37 (s, 0.75H), 2.38 (s, 2.25H) ppm.
22. (a) Daidone, G.; Plascia, F.; Maggio, B.; Raffa, D.; Cutuli, V. M. C.; Mangano,NG.;Caruso,A. Arch. Pharm. Pharm. Med. Chem. 2001, 334, 153-156;
23. (b) Daidone,G.; Plascia, F.; Maggio,B.; Raffa,D.; Caruso,A.; Cutuli, V. M. C.; Amico-Roxas,M. Eur. J. Med. Chem. 1994, 29, 707-711;
24. (c) Daidone, G.; Maggio, B.; Plescia, S.; Raffa, D.; Schilliaci,D.; Caruso, A.; Cutuli, V. M. C.; Amico- Roxas, M. Farmaco. 1998, 53, 350-356;
25. (d) Daidone, G.; Raffa, D.; Maggio, B.; Plescia, F.; Cutuli, V. M. C.; Mangano, N. G.; Caruso,A.; Arch. Pharm. Pharm. Med. Chem. 1999, 332, 50-54.
26. Crystallographic data (excluding structure factors) for the structures in this paper have been deposited with the Cambridge Crystallographic Data Centre as supplementary publication nos. CCDC 639095 (4c) & 635094 (8). Copies of the data can be obtained, free of charge, on application to CCDC, 12 Union Road, Cambridge CB2 1EZ, UK, (fax: +44-(0)1223-336033 or e-mail: deposit@ccdc.cam.ac.uk).